isoxazoles has been researched along with Aspergillosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glamoclija, J; Kataranovski, M; Mirkov, I; Stojanovic, I; Stosic-Grujicic, S | 1 |
Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Okubo, M; Shirotori, S; Sonoda, J; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
Bond, J; Finn, S; McCarthy, D; Quinn, C; Sheahan, K | 1 |
3 other study(ies) available for isoxazoles and Aspergillosis
Article | Year |
---|---|
A role for macrophage migration inhibitory factor in protective immunity against Aspergillus fumigatus.
Topics: Adaptive Immunity; Animals; Aspergillosis; Aspergillus fumigatus; Cytokines; Enzyme Inhibitors; Female; Immunity, Innate; Inflammation; Intramolecular Oxidoreductases; Isoxazoles; Macrophage Migration-Inhibitory Factors; Macrophages; Mice; Mice, Inbred C57BL; Mice, Knockout; Signal Transduction | 2011 |
Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis.
Topics: Aminopyridines; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Candidiasis; Female; Fusariosis; Fusarium; Isoxazoles; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 2011 |
Angioinvasive aspergillosis presenting as neutropenic colitis.
Topics: Adalimumab; Adjuvants, Immunologic; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Aspergillosis; Cholecystectomy; Colitis; Colon; Diagnosis, Differential; Female; Hernia, Abdominal; Humans; Immunocompromised Host; Isoxazoles; Leflunomide; Pancytopenia; Rheumatic Diseases | 2006 |